Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Lymphokines – e.g. – interferons – interlukins – etc.
Reexamination Certificate
2005-08-30
2005-08-30
Andres, Janet (Department: 1646)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Lymphokines, e.g., interferons, interlukins, etc.
C435S069510
Reexamination Certificate
active
06936695
ABSTRACT:
Illustrated is the preparation and expression of manufactured genes capable of directing synthesis of human immune and leukocyte interferons and of other biologically active proteinaceous products, which products differ from naturally-occurring forms in terms of the identity and/or relative position of one or more amino acids, and in terms of one or more biological and pharmacological properties but which substantially retain other such properties.
REFERENCES:
patent: 4237224 (1980-12-01), Cohen et al.
patent: 4264731 (1981-04-01), Shine
patent: 4273875 (1981-06-01), Manis
patent: 4293652 (1981-10-01), Cohen
patent: 4332892 (1982-06-01), Ptashne et al.
patent: 4338397 (1982-07-01), Gilbert et al.
patent: 4342832 (1982-08-01), Goeddel et al.
patent: 4349629 (1982-09-01), Carey et al.
patent: 4366246 (1982-12-01), Riggs
patent: 4394443 (1983-07-01), Weissman et al.
patent: 4414150 (1983-11-01), Goeddel
patent: 4456748 (1984-06-01), Goeddel
patent: 4457867 (1984-07-01), Ishida
patent: 4518584 (1985-05-01), Mark et al.
patent: 4652639 (1987-03-01), Stabinsky
patent: 4663290 (1987-05-01), Weis et al.
patent: 4678751 (1987-07-01), Goeddel et al.
patent: 4695623 (1987-09-01), Stabinsky
patent: 4727138 (1988-02-01), Goeddel et al.
patent: 4762791 (1988-08-01), Goeddel et al.
patent: 4855238 (1989-08-01), Gray et al.
patent: 4925793 (1990-05-01), Goeddel et al.
patent: 4929554 (1990-05-01), Goeddel et al.
patent: 0028033 (1981-05-01), None
patent: 0046039 (1982-02-01), None
patent: 0063482 (1982-10-01), None
patent: 0077670 (1983-04-01), None
patent: 0077670 (1983-04-01), None
patent: 083777 (1983-07-01), None
patent: 0095350 (1983-11-01), None
patent: 0098118 (1984-01-01), None
patent: 0121157 (1984-10-01), None
patent: 0128467 (1984-12-01), None
patent: 0136620 (1985-04-01), None
patent: 0146354 (1985-06-01), None
patent: 0146413 (1985-06-01), None
patent: 0146944 (1985-07-01), None
patent: 0422697 (1991-04-01), None
patent: 0423845 (1991-04-01), None
patent: 0424990 (1991-05-01), None
patent: 2040292 (1980-08-01), None
patent: 2063882 (1981-06-01), None
patent: 2068970 (1981-08-01), None
patent: 2071108 (1981-09-01), None
patent: 2079291 (1982-01-01), None
patent: 2091268 (1982-07-01), None
patent: WO 81/03498 (1981-12-01), None
patent: WO 83/04053 (1983-11-01), None
patent: WO 85/04186 (1985-09-01), None
patent: WO 85/05619 (1985-12-01), None
patent: WO 86/06079 (1986-10-01), None
patent: WO 92/06707 (1992-04-01), None
patent: WO 93/21229 (1993-10-01), None
Agarwal et al., “Total Synthesis of the Gene for an Alanine Transfer Ribonucleic Acid from Yeast,”Nature, 227: 27-34 (1970).
Aharonowitz et al., “The Microbiological Production of Pharmaceuticals,”Sci. Amer., 245(3):140-152 (Sep., 1981).
Alton et al., “Production, Characterization and Biological Effects of Recombinant DNA Derived Human IFN-α and IFN-gamma Analogs,”The Biology of the Interferon System, DeMaeyer et al. (eds.), Elsevier Science Pub. B. V., pp. 119-127 (1983) (Proceedings 2nd Int. Meeting).
Andrews et al., “Amino Acid Sequence of the Variable Regions of Heavy Chains from Two Idiotypically Cross-Reactive Human IgM Anti-Gamma-Globulins of the Wa Group,”Biochemistry, 20:5828-5830 (1981).
Berger et al., “Characterization of Interferon Messenger RNA Synthesis in Namalva Cells,”J. Biol. Chem., 225(7):2955-2961 (1980).
“Biological Division Awards to Goeddel and Tijian,”Chem&Eng. News, (Nov. 14, 1983).
Campbell et al.,“A microplaque reduction assay for human and mouse interferon1,”Can. J. Microbiol., 21:1247-1253 (1975).
Capon et al., “Bovine IFN Gene Families and Production of Ha-IFNs by Yeast andE. coli,” The 3rd Annual International Congress for Interferon Research, (Abstract Only).
Dalboge et al., “In Vivo Processing of N-Terminal Methionine inE. coli,” FEBS, 266(1,2,1-3):1-3 (Jun. 1990).
de Ley et al., “Interferon Induced in Human Leukocytes by Mitogens Production, Partial Purification and Characterization,”Eur. J. Immunol., 10:877-883 (1980).
Derynck et al., “Synthesis of Human Interferon-Gamma Derivatives inE. coli,” Memo I A1193/2 (Aug., 1982).
Devos et al., “Molecular Cloning of Human Immune Interferon cDNA and its Expression in Eukaryotic Cells,”Nucl. Acids Res., 10(8):2487-2501 (Apr. 24, 1982).
Dianzani et al., “Immune and virus-induced interferons may activate cells by different derepressional mechanisms,”Nature, 283:400 (1980).
Doolittle R.F., “Sequencing Peptides and Proteins Lacking Free α-Amino Groups,”Advanced Methods in Protein Sequence Determination, Needleman (ed.), Springer-Verlag, Berlin, pp. 38-54 (1977).
Edge et al., “Total Synthesis of a Human Leukocyte Interferon Gene,”Nature, 292(5825):756-762 (Aug. 20, 1981).
Epstein, “Interferon-Gamma: Is It Really Different From the Other Interferons?” in Interferon, Gresser (ed.), Academic Press, 3:13-44 (1981).
Epstein L.B., “Interferon as a Model Lymphokine,”Fed. Proc., 40(1):56-61 (1981).
Epstein, L.B., “Interferon-gamma: success, structure and speculation,”Nature, 295:453-454 (1982).
Fiers et al., “Molecular-Biological Studies on Human Fibroblast Interferon, Immune Interferon and Interleukin 2 Genes,”The Biology of the Interferon System, Elsevier Sci. Pub. B. V., DeMaeyer et al., (eds.), (1983).
Fiers et al., “The Human Fibroblast and Human Immune Interferon Genes and Their Expression in Homologous and Heterologous Cells”,Philos. Trans. R. Soc. Lond. B. Biol. Sci., 299(1094):29-38 (Sep. 24, 1982).
Fishbein, G.W., “Suntory Expresses Synthetic Gamma Interferon Gene,” Newswatch, 2:5 (1982).
Gamma Winners,Nature, 294:7 (1981).
Gillis et al., “Biochemical Characterization of Lymphocyte Regulatory molecules: II. Purification of a Class of Rat and Human Lymphokines,”J. Immunol., 124(4):1954-1962 (Apr. 1980).
Goeddel et al., “Expression inEscherichia coliof chemically Synthesized Genes for Human Insulin,”Proc. Nat'l Acad. Sci., USA, 76:106-110 (1979).
Goeddel et al., “Human Leukocyte Interferon Produced byE. coliis Biologically Active,”Nature, 287:411-416 (1980).
Goeddel et al., “Synthesis of Human Fibroblasts Interferon byE. coli,” Nucl. Acids Res., 8(18):4057-4074 (Sep. 25, 1980).
Goeddel et al., “The Structure of Eight Distinct Cloned Human Leukocyte Interferon cDNAs,”Nature, 290(5801):20-26 (Mar. 5, 1981).
Goeddel et al., Direct Expression inEscherichia coliof a DNA Sequence Coding for Human Growth Hormone,Nature, 281:544-548 (1981).
Gold et al., “Translational Initiation in Prokaryotes,”Ann. Rev. Microbiol., 35:365-403 (1981).
Grantham et al., “Codon Catalog Usage and the Genome Hypothesis,”Nucl. Acids Res., 8(1):r49-62 (1980).
Grantham et al., “Codon Catalog Usage is a Genome Strategy Modulated for Gene Expressivity,”Nucl. Acids Res., 9(1):r43-r74 (1981).
Grantham et al., “Codon Frequencies in 119 Individual Genes Confirm Consistent (Choices of Degenerate Bases According to Genome Type,”Nucl. Acids Res., 8(9):1893-1912 (1980).
Gray et al., “Expression of Human Immune Interferon cDNA inE. coliand Monkey Cells,”Nature, 295:503-508 (Feb. 11, 1982).
Gray et al., “Structure of the Human Immune Interferon Gene,”Nature, 298:859-863 (Aug. 26, 1982).
Hamer et al., “Expression of the chromosomal mouse βmaj-globin gene cloned in SV40,”Nature, 281:35 (1979).
Hitzeman et al., “Expression of a Human Gene for Interferon in Yeast,”Nature, 293:717721 (Oct. 29, 1981).
Horlein et al., Amino Acid Sequence of the Aminoterminal Segment of Dermatosparactic Calf-Skin Procollagen Type I,Eur. J. Biochem. 99:31-38 (1979).
Itakura et al., “Expression inEscherichia coliof a Chemically Synthesized Gene for the Hormone Somatostatin,”Science, 198:1056-1063 (1977).
Khorana, “Tota
Alton Norman K.
Peters Mary A.
Snitman David L.
Stabinsky Yitzhak
Andres Janet
Intermune, Inc.
Marshall & Gerstein & Borun LLP
LandOfFree
Manufacture and expression of large structural genes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Manufacture and expression of large structural genes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Manufacture and expression of large structural genes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3496101